Analyst Ratings for Seattle Genetics (sgen)

sgen Rating Summary

sgen Price Target Summary

* Over Last 12-Mos
  |   Expand Research on sgen
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $51.00 (+22.9%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/9/2014 UBS Upgrade Buy
(Neutral)
N/A
(N/A)
35.46 41.51 17.06% Details
5/6/2014 BofA/Merrill Lynch Upgrade Neutral
(Underperform)
N/A
(N/A)
35.10 41.51 18.26% Details
Like SGEN Ratings? Also take a look at NDAQ, MDVN, ISIS, FSLR

SGEN Ratings News